NovaMed Pharmaceuticals
Acquired by SciClone
Develops innovative therapies to address unmet medical needs in various diseases.
Sector
Life SciencesCategory
TherapeuticsLocation
Shanghai, ChinaInitial Investment
2007
Develops innovative therapies to address unmet medical needs in various diseases.
NovaMed Pharmaceuticals is a revenue-generating specialty pharmaceutical company focused on the commercialization of branded innovative therapies for diseases with high unmet medical need in China, including oncology, urology, and cardiovascular. NovaMed was acquired by SciClone.